5Wozney JM. The bone morphogenetic proteinfamily: multifunctional cellular regulators in the embryo and adult[J].Eur J OralSci,1998,106(Suppl 1):160~166.
6Locombe D,Toutain A,Gorlin RJ. Clinical identification of a human equivalent to theshort ear (se)murine phenotype[J].Ann Genet,1994,37(4):184~191.
7Jena N,Martin-Seisdedos C,McCue P,et al.BMP7 null mutation in mice:developmentaldefects in skeleton,kidney,and eye[J].Exp Cell Res,1997,230(1):28~37.
8Gannon FH,Kaplan FS,Olmsted E,et al.Bone morphogenetic protein 2/4 in earlyfibromatous lesions of fibrodysplasia ossificans progressiva[J].HumPathol,1997,28(3):339~343.
2Shuford JA, Steckelberg JM. Role of oral antimicrobial therapy in the management of osteomyelitis [J]. Curr Opin Infect Dis,2003, 16(6):515 -519.
3Tautenhahn J, Pross M, Kuhn R, et al. The use of v.a.C.-system in wound management for borderline indications [J]. Zentralbl Chir,2004,129(Suppl 1):S12-S13.
4Polykandriotis E, Kneser U, Kopp J, et al. Modified gloving technique for vacuum therapy in the hand [J]. Zentralbl Chir,2010,131(Suppl 1): $36-$39.
5Ries MD, Bozic KJ. Medial gastrocnemius flap coverage for treatment of skin necrosis after total knee arthroplasty [J]. Clin Orthop Relat Res,2006,446:186-192.
6Jepegnanam TS, Boopalan PR, Nithyananth M, et al. Reconstruction of complete knee extensor mechanism loss with gastrocnemius flaps [J]. Clin Orthop,2009,467(10):2662-2667.
7Nejedly A, Dzupa V, Z0horka J, et al. Muscle flap transfer of the treatment of infected tibial and malleolar fractures and chronic osteomyelitis of the tibia [J]. Acta Chir Orthop Traumatol Cech, 2007,74(3): 162-170.